For PDF copy of slides: NAFLD and NASH
Dr. Zobair Younassi gave a recent virtual grand rounds –here are some of the slides:
Epidemiology:
Natural History:
- Progression of disease is not linear
- Fatty liver disease is a multisystem disorder. Cardiovascular disease is leading cause of death in patients with fatty liver disease
- Fatigue (~50%) is common with fatty liver disease
Main treatment:
- Weight loss -Mediterranean diet may be helpful
- Exercise
- No FDA-approved treatments, though pioglitizone supported by AASLD for biopsy-proven NASH
- Public health interventions are needed
